Back to User profile » Prof. Dr. Juei-Tang Cheng

Papers published by Prof. Dr. Juei-Tang Cheng:


Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats

Kuo FY, Cheng KC, Li Y, Cheng JT, Tsai CC

Diabetes, Metabolic Syndrome and Obesity 2020, 13:2269-2277

Published Date: 29 June 2020

Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report

Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT

Diabetes, Metabolic Syndrome and Obesity 2018, 11:901-911

Published Date: 7 December 2018

Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals

Li Y, Cheng KC, Niu C, Lo S, Cheng JT, Niu H

Drug Design, Development and Therapy 2017, 11:1127-1134

Published Date: 5 April 2017

Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay

Lo SH, Cheng KC, Li YX, Chang CH, Cheng JT, Lee KS

Drug Design, Development and Therapy 2016, 10:2669-2676

Published Date: 22 August 2016

Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats

Niu HS, Chang CH, Niu CS, Cheng JT, Lee KS

Drug Design, Development and Therapy 2016, 10:1877-1884

Published Date: 3 June 2016

Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats

Niu HS, Liu IM, Niu CS, Ku PM, Hsu CT, Cheng JT

Drug Design, Development and Therapy 2016, 10:971-978

Published Date: 2 March 2016

Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals

Niu HS, Ku PM, Niu CS, Cheng JT, Lee KS

Drug Design, Development and Therapy 2015, 9:5625-5632

Published Date: 14 October 2015

Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats

Lin CM, Tsai JT, Chang CK, Cheng JT, Lin JW

Drug Design, Development and Therapy 2015, 9:4709-4717

Published Date: 14 August 2015